ストックスクリーナーアプリを入手
52.78
0.75%
-0.53
前日終値:
$53.31
開ける：
$52.535
24時間の取引高:
150.57K
Relative Volume:
0.33
時価総額：
$3.76B
収益：
$751.00K
当期純損益:
$-74.57M
株価収益率:
-47.85
EPS:
-1.1031
ネットキャッシュフロー:
$-55.52M
1週間 パフォーマンス:
-4.15%
1か月 パフォーマンス:
+4.94%
6か月 パフォーマンス:
+139.42%
1年 パフォーマンス:
+201.32%
1日の値動き範囲:
$52.48
$53.79
1週間の範囲:
$48.61
$54.81
52週間の値動き範囲:
$12.56
$58.90
Pulse Biosciences Inc Stock (PLSE) Company Profile
Compare PLSE vs ISRG, BDX, RMD, ALC, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
52.74 | 3.79B | 751.00K | -74.57M | -55.52M | -1.1031 |
ISRG
Intuitive Surgical Inc
|
400.64 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
182.88 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
224.54 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
65.44 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.18 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-30 | 開始されました | Mizuho | Outperform |
| 2025-07-07 | 開始されました | Oppenheimer | Outperform |
| 2021-07-27 | 開始されました | Stephens | Overweight |
| 2021-03-11 | 開始されました | Maxim Group | Buy |
| 2021-01-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-12 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Pulse Biosciences Inc (PLSE) 最新ニュース
Why is Pulse Biosciences stock surging today? By Investing.com - Investing.com Nigeria
Pulse Biosciences stock hits all-time high at 56.15 USD By Investing.com - Investing.com Nigeria
Freedom Capital initiates Pulse Biosciences stock with buy rating By Investing.com - Investing.com Australia
Why Pulse Biosciences Stock Popped Today - theglobeandmail.com
Freedom Capital Markets Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $73 - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Pulse Biosciences stock hits all-time high at 56.15 USD - investing.com
$Pulse Biosciences (PLSE.US)$ the squeeze is onnnnnnnn - Moomoo
PLSE Initiates Coverage by Freedom Capital Markets -- Price Targ - GuruFocus
Freedom Capital initiates Pulse Biosciences stock with buy rating - investing.com
(PLSE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Pulse Biosciences Stock Price Forecast. Should You Buy PLSE? - StockInvest.us
Pulse Biosciences stock holds steady as investors eye recent clinical and financial progress - AD HOC NEWS
Pulse Biosciences (PLSE) Grants Equity Awards to New Hires Amid High Price-to-Sales Valuation - GuruFocus
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Pulse Biosciences Inc (DE) (PLSE) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock By Investing.com - Investing.com Australia
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock - Investing.com India
COO pays nearly $50 a share for Pulse Biosciences (NASDAQ: PLSE) - Stock Titan
Pulse Biosciences Inc (DE) (PLSE) Peer Comparison – Compare with Others - Value Research
$Pulse Biosciences (PLSE.US)$ New ATH 🔥 - Moomoo
Pulse Biosciences Reports Teplitsky Liane Rae as New Insider COO - Kalkine Media
Pulse Biosciences stock hits new high as insider buying fuels rally - ad-hoc-news.de
Pulse Biosciences stock hits all-time high at 51.0 USD - Investing.com
Pulse Biosciences stock hits all-time high at 51.0 USD By Investing.com - Investing.com Canada
Pulse Biosciences (PLSE) Slips 2% as Shares Approach Key Support at $45.19IV Crush Alert - vinanet.vn
Pulse Biosciences COO Liane Teplitsky buys $99,965 in stock By Investing.com - Investing.com Nigeria
PLSE | Pulse Biosciences, Inc Common FinancialsIncome Statement - Quiver Quantitative
Pulse Biosciences (NASDAQ: PLSE) links CFO options to value and revenue goals - Stock Titan
Pulse Biosciences Inc (DE) (PLSE) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Pulse Biosciences CFO Jon Skinner files initial beneficial ownership statement - Bitget
Pulse Biosciences (PLSE), Why Is Attention Building Around It? - simplywall.st
Total assets of Pulse Biosciences, Inc. – HAM:6L8 - TradingView
Operating cash flow per share of Pulse Biosciences, Inc. – HAM:6L8 - TradingView
Free cash flow per share of Pulse Biosciences, Inc. – HAM:6L8 - TradingView
Pulse Biosciences stock hits all-time high at 48.92 USD - Investing.com
$Pulse Biosciences (PLSE.US)$ shorties getting squeezed - Moomoo
Pulse (PLSE) Results Review: EPS Clears the Reported Estimate; Trading Move: Shares Rise 2.22% in the Latest ReadingDividend Growth Analysis - Vinanet
Bank of America Corp DE Grows Stake in Pulse Biosciences, Inc $PLSE - MarketBeat
Pulse Biosciences (PLSE) Launched A $75 Million Offering, Is The Upside Already Priced In? - Sahm
Pulse Biosciences (NASDAQ:PLSE) Sets New 1-Year HighHere's Why - MarketBeat
Pulse (PLSE) Earnings Review: EPS Exceeds Its Estimate in the Current Update; Reaction Snapshot - vinanet.vn
This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm
This Okta Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday - Benzinga
Pulse Biosciences, Inc (NASDAQ:PLSE) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Needham & Company LLC Initiates Coverage on Pulse Biosciences (NASDAQ:PLSE) - MarketBeat
PLSE Initiates Coverage On by Needham -- Price Target Announced at $58.00 - GuruFocus
Pulse Biosciences Inc (PLSE) 財務データ
収益
当期純利益
現金流量
EPS
Pulse Biosciences Inc (PLSE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Teplitsky Liane Rae | Chief Operating Officer |
Aug 31 '26 |
Buy |
48.80 |
1,024 |
49,971 |
3,094 |
| Teplitsky Liane Rae | Chief Operating Officer |
Aug 28 '26 |
Buy |
48.35 |
1,034 |
49,994 |
2,070 |
| Teplitsky Liane Rae | Chief Operating Officer |
Aug 26 '26 |
Buy |
48.23 |
1,036 |
49,971 |
1,036 |
| LAVIOLETTE PAUL A | Chief Executive Officer |
May 11 '26 |
Buy |
19.69 |
15,000 |
295,350 |
15,000 |
| DUGGAN ROBERT W | Director |
May 11 '26 |
Buy |
19.69 |
660,233 |
12,999,988 |
48,211,433 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 18 '26 |
Option Exercise |
1.53 |
5,000 |
7,650 |
48,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 18 '26 |
Sale |
23.64 |
5,000 |
118,200 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 12 '26 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 13 '26 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 17 '26 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
3.86%
大文字化:
|
ボリューム (24 時間):